Medical/Pharmaceuticals News & Press Release Distribution

Kira Pharmaceuticals Appoints Angela Yan as President of China and Asia Development and Operations

CAMBRIDGE, Mass. and SUZHOU, China, Aug. 2, 2022 /PRNewswire/ -- Kira Pharmaceuticals, a global clinical-stage biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, today announced the appointment ofAngela (Hui) Yan as President of China and Asi...

2022-08-02 07:00 4805

Kira Pharmaceuticals Appoints Angela Yan as President of China and Asia Development and Operations

Telix APAC Report: Regulatory Progress for Prostate and Kidney Cancer Imaging

MELBOURNE, Australia, Aug. 2, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today reports on regulatory progress for the Company's core prostate and kidney cancer imaging programs in theAsia Pacific (APAC) Operating Region, including progress in the major marke...

2022-08-02 06:54 3231

EXPERIENCES OF RACISM ASSOCIATED WITH POOR MEMORY, INCREASED COGNITIVE DECLINE

SAN DIEGO, Aug. 1, 2022 /PRNewswire/ -- Experiences of structural, interpersonal and institutional racism are associated with lower memory scores and worse cognition in midlife and old age, especially among Black individuals, according to studies reported today at theAlzheimer's Association Inter...

2022-08-01 23:00 4350

"OpenDEL®3.0 - DRUG DISCOVERY PARTNER" webinar offered by HitGen and Endpoints News coming up on Thursday 4th August

CHENGDU, China, Aug. 1, 2022 /PRNewswire/ -- "OpenDEL®3.0 – DRUG DISCOVERY PARTNER" webinar will be jointly held by HitGen Inc. and Endpoints News on Thursday 4th August, to present you with a high-quality DEL product with all DEL information sharing and technical support. Dr. Guansai Liu, Execut...

2022-08-01 22:00 2915

OriCell Therapeutics Raises Over $120 Million in Series B Financing Led by Qiming Venture Partners and Quan Capital to Advance Cell Therapies for Cancer Immunology

2022 is set to be a milestone year for OriCell who has been focusing on the field of cancer immunotherapy for more than seven years and is fully committed to becoming an innovative global drug developer. SHANGHAI, Aug. 1, 2022 /PRNewswire/ -- OriCell Therapeutics (S...

2022-08-01 22:00 3668

New Immunotherapy Combination Study for Nasopharyngeal Cancer Demonstrates Effectiveness of Lunit AI as Predictive Aid in Treatment Outcome--Published in Clinical Cancer Research

* Recent clinical trial on combination immunotherapy for nasopharyngeal cancer provides evidence for Lunit SCOPE IO's ability to predict patient response. * Analysis indicates Immune-excluded Immune Phenotype acts as a resistance mechanism against combination immunotherapy, further supporting...

2022-08-01 21:00 2511

New Immunotherapy Combination Study for Nasopharyngeal Cancer Demonstrates Effectiveness of Lunit AI as Predictive Aid in Treatment Outcome--Published in Clinical Cancer Research

GreenLight Biosciences and Samsung Biologics complete first commercial-scale engineering run for mRNA Covid-19 vaccine

* GreenLight's messenger RNA production process is transferable to large-scale equipment and CMO facilities * Technology transfer and scale-up from lab bench to Samsung's commercial facility was completed in seven months * GreenLight's mRNA synthesis reaction had a titer of 12g/L at a commer...

2022-08-01 21:00 3230

Gracell Biotechnologies Appoints Accomplished Clinical Leader Dr. Wendy Li as Chief Medical Officer

Dr. Li brings deep oncology clinical development, medical affairs and U.S. regulatory experience SAN DIEGO, Calif. and SUZHOU and SHANGHAI, China, Aug. 1, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical compa...

2022-08-01 20:00 2800

Meihua International Medical Technologies Co., Ltd. Reports 2021 Financial Year Results

YANGZHOU, China, Aug. 1, 2022 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries inChina, today reported its financial res...

2022-08-01 19:00 3317

66% of diagnostic biopsies for common skin cancer can be avoided using Michelson Diagnostics' VivoSight OCT laser scanner

MAIDSTONE, England, Aug. 1, 2022 /PRNewswire/ -- A major study published in leading cancer journal, The Lancet Oncology1 have ground-breaking findings on Michelson Diagnostics, the UK based medical device company that use multi-beam Optical Coherence Tomography ('OCT') technology, which can trans...

2022-08-01 19:00 1051

66% of diagnostic biopsies for common skin cancer can be avoided using Michelson Diagnostics' VivoSight OCT laser scanner

OPEN Health to acquire leading US medical communications platform The CM Group from NaviMed Capital

LONDON and HINGHAM, Mass. and WASHINGTON, Aug. 1, 2022 /PRNewswire/ -- OPEN Health, a global provider of scientific communications and market access services, announced that it signed a binding agreement to acquire The CM Group, a leading US domestic medical communications platform from NaviMed C...

2022-08-01 16:00 2322

Eccogene Announces US IND Approval for THRβ agonist ECC4703

SHANGHAI, Aug. 1, 2022 /PRNewswire/ -- Eccogene announced that the U.S. Food and Drug Administration (FDA) has approved the investigational new drug (IND) application to commence Phase I trial of its thyroid hormone receptor agonist ECC4703 in U.S. This study will evaluate the safety, tolerabilit...

2022-08-01 15:00 2543

Nippon Express (China) Opens New Healthcare Branch in Shanghai

- Company Is Stepping up Its Efforts in China's Pharmaceutical Industry - TOKYO, Aug. 1, 2022 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereafter "NX China"), a group company of NIPPON EXPRESS HOLDINGS, INC., has established a Healthcare Branch inShanghai to strengthen its efforts in Chin...

2022-08-01 14:22 2257

Nippon Express (China) Opens New Healthcare Branch in Shanghai

- Company Is Stepping up Its Efforts in China's Pharmaceutical Industry - TOKYO, Aug. 1, 2022 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereafter "NX China"), a group company of NIPPON EXPRESS HOLDINGS, INC., has established a Healthcare Branch inShanghai to strengthen its efforts in Chin...

2022-08-01 14:17 2283

Nippon Express (China) Opens New Healthcare Branch in Shanghai

- Company Is Stepping up Its Efforts in China's Pharmaceutical Industry - TOKYO, Aug. 1, 2022 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereafter "NX China"), a group company of NIPPON EXPRESS HOLDINGS, INC., has established a Healthcare Branch inShanghai to strengthen its efforts in Chin...

2022-08-01 14:00 2875

Pharming Group Receives Accelerated Assessment in Europe for leniolisib for the Treatment of Rare Immunodeficiency, APDS

EMA accelerated assessment allows a shorter review period for leniolisib from a standard 210 days to 150 days Pharming is on track to submit its Marketing Authorisation Application for leniolisib in H2 2022 LEIDEN, the Netherlands, Aug. 1, 2022 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or...

2022-08-01 13:00 4124

Alps Pharmaceutical confirms through human pharmacokinetic studies that its newly developed natural quercetin formulation can significantly reduce quercetin usage

HIDA, Japan, Aug. 1, 2022 /PRNewswire/ -- On Aug 02, 2022, with the recent surge in raw material prices and the continued scarcity of quercetin in the market, Alps Pharmaceutical Ind. Co., Ltd. (Hida,Japan, President: Osamu Ushimaru) announced that it has confirmed through human pharmacokinetic s...

2022-08-01 12:28 2101

Active Motif Incorporated Licenses Targeted Transposition to Diagenode S.A. Technology

CARLSBAD, Calif., Aug. 1, 2022 /PRNewswire/ -- Active Motif Incorporated, a company with the vision of bringing epigenetics more deeply into precision medicine, announced that it has non-exclusively licensed its foundational patents in transposition for use in CUT&Tag epigenetic assays to Diageno...

2022-08-01 11:30 2719

CHEMICAL INDUSTRIES (FAR EAST) LIMITED MARKS 60TH ANNIVERSARY WITH $60,000 DONATION TO SOULJOURN

SINGAPORE, Aug. 1, 2022 /PRNewswire/ -- Founded in 1962, Chemical Industries (Far East) Limited (CIL) commemorated its 60th anniversary with a dinner for employees, customers and business partners at The Capitol Kempinski Hotel on 29 th July 2022. As part of its commemoration, CIL made a $60,000 d...

2022-08-01 10:40 4595

CHEMICAL INDUSTRIES (FAR EAST) LIMITED MARKS 60TH ANNIVERSARY WITH $60,000 DONATION TO SOULJOURN

PERSISTENT LOSS OF SMELL DUE TO COVID-19 CLOSELY CONNECTED TO LONG-LASTING COGNITIVE PROBLEMS

FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2022 Also, ICU Stay May Double Risk of Dementia in Older Adults SAN DIEGO, Aug. 1, 2022 /PRNewswire/ -- New insights into factors that may predict, increase or protect against the impact of COVID-19 and the pandemic on memory and thinkin...

2022-08-01 09:03 4061